Arginine Butyrate

N/A

Report date: 2023/04/23 15:17:08

Base Information

Drug NameArginine Butyrate
Drug Alias Name精氨酸丁酸盐VX-105HQK-1004
ClassificationSmall molecules > Amino acid supplement, Lipids and Vitamins
Mechanisms of ActionThymidine kinase stimulants
TargetsThymidine kinase
Therapy Area/IndicationsSchizophreniaLymphoproliferative DisordersLymphocytosis +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesItalyGermany +[5] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBoston University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBoston Medical Center IncUniversity Of Massachusetts Medical SchoolHemaquest Pharmaceuticals Inc +[4] 
Active IndicationsN/A
Inactive IndicationsSchizophreniaLymphoproliferative DisordersLymphocytosis +[8] 

Other Information

ATC CodeN/A
Related LinksN/A